1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
65713368BE4AF8A5785256D33007AC50A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/communicating-clinical-trial-results-to-mcos-consumers-investors?opendocument
18
19opendocument
203.80.128.196
21
22
23
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Communicating Clinical Trial Results

Communicating Clinical Trial Results to MCOs, Consumers & Investors

DB Image

ID: 4431


Features:

Metrics, Graphics


Words: 3,683


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
This 12-page document includes best practices and supporting graphics for communicating clinical trial results to the managed care community, consumers and investors. While physicians are the primary audience for clinical trial results, successful communication to these groups can help drive uptake of a product by bringing its benefits to the attention of a wider audience. This research originated from Best Practice, LLC's consulting services.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Abbott Laboratories; Sanofi-aventis; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; GlaxoSmithKline; Janssen; Merck; Pharmacia; Novartis; Schering-Plough


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.